baber/WOPTO huggingface dataset:
Patent AU-2020213421-A1 (AU)
Title: Electrospun biocompatible fiber compositions
Inventor: JOHNSON JED
IPC: A61L17/08
Filed: 2020-08-10
Abstract: A composition comprising a plurality of electrospun fiber fragments comprising at least one 
polymer, a plurality of electrospun fiber fragment clusters comprising at least one polymer, 
and, optionally, a carrier medium, is disclosed. Also disclosed is a kit comprising a first 
component of a plurality of electrospun fiber fragments, and a second component of a carrier 
medium. Also disclosed is a composition comprising a plurality of micronized electrospun fiber 
fragments, a carrier medium, and, optionally, a plurality of cells. Also disclosed is a 
biocompatible textile comprising a plurality of micronized electrospun fiber fragments. Also 
disclosed is a biocompatible suture comprising at least one electrospun fiber. Also disclosed is 
a method for making a biocompatible suture, comprising electrospinning a polymer solution 
onto a receiving surface, forming one or more non-overlapping nanofiber threads, removing 
the nanofiber threads from the receiving surface, and cutting the nanofiber threads into one or 
more biocompatible sutures. See Fig. 1.
WO 2015/153011 PCT/US2015/016973 
1/13 
140 
145a 
125a 
125b 
145b 
130 
145c 
.- 120 
105 
115 
110 
FIG. 1
Patent AU-2020219149-A1 (AU)
Title: A method for the treatment or prophylaxis of cancer by targeting the extracellular portion of keratin 14 (KRT14) residing on cancer cells
Inventor: STEPHENS ANDREW NICHOLAS
IPC: A61K39/395
Filed: 2020-02-07
Abstract: Disclosed herein are methods, uses and compositions for the treatment or prophylaxis of cancer in a mammalian subject comprising administering to the subject an amount of an agent which targets an extracellular portion of KRT14 or its functional homolog or variant thereof resident on cancer cells or an agent which induces production of an antagonist of the extracellular portion of KRT14 or its functional homolog or variant on cancer cells. The present disclosure also extends to methods of monitoring and / or diagnosing cancer in a subject.
Patent AU-2020222538-A1 (AU)
Title: Device Management System
Inventor: KITAMURA MASAYASU
IPC: G06F13/00
Filed: 2020-02-05
Abstract: An apparatus management system comprising a control terminal (20) and a management device (30). The control terminal (20) collects information pertaining to an air conditioner (10). The management device (30) performs communication with the control terminal (20) via a communication network. The management device (30) has a communication unit and an abnormality determination unit. The communication unit accepts the abnormality content of the air conditioner (10) that is inputted thereto. The abnormality determination unit designates detailed operation information in accordance with an estimated abnormality content. The detailed operation information is used for specifying the cause of abnormality when abnormality of the air conditioner (10) is estimated. The control terminal (20) has a transmission processing unit. The transmission processing unit transmits the detailed operation information on the basis of designation of the abnormality determination unit.
Patent AU-2020228514-A1 (AU)
Title: Cancer therapy using 3,5-disubstituted benzene alkynyl compound and immune checkpoint inhibitor
Inventor: YONEKURA KAZUHIKO
IPC: A61K39/395
Filed: 2020-02-28
Abstract: The present disclosure addresses the problem of providing a new combination therapy that exhibits a superior anti-tumor effect in cancer patients who have a resistance to immune checkpoint inhibitors, said combination therapy involving (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidine-1-yl(pyrrolidine-1-yl)prop-2-en-1-one or a salt thereof. The present disclosure provides an anti-tumor agent for concomitant administration with an immune checkpoint inhibitor (excluding pembrolizumab) to cancer patients who have a resistance to immune checkpoint inhibitors, said anti-tumor agent including a (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidine-1-yl(pyrrolidine-1-yl)prop-2-en-1-one or a salt thereof as an active component.
Patent AU-2020240120-A1 (AU)
Title: NGF antagonists for medical use
Inventor: ZHAN HANGJUN
IPC: C07K14/47
Filed: 2020-03-20
Abstract: Provided are various embodiments relating to TrkA ECD polypeptides from companion animal species that bind to NGF. Such polypeptides can be used in methods to treat NGF-induced condition related to chronic pain and/or inflammatory pain in companion animals, such as canines, felines, and equines.
Patent AU-2020250013-A1 (AU)
Title: Template and method for measuring the cross section of a graft
Inventor: LUCCHINI RICCARDO
IPC: A61F2/08
Filed: 2020-03-24
Abstract: According to a first aspect thereof, the invention relates to a template for measuring the cross section of a graft. The template comprises a first half-body and a second half-body, wherein: - the two half-bodies are mutually secured such that they can rotate the one with respect to the other around an axis
Patent AU-2020267383-A1 (AU)
Title: Product containment guard for a conveyor
Inventor: KOKX DAVID A
IPC: B65G21/10
Filed: 2020-05-04
Abstract: A conveyor employs an adjustable product containment guard adjacent to a carryway for containing product on the carryway. The product containment guard is mounted to an end plate that includes multiple seats for moving the product containment guard between different positions.
Patent AU-2020311851-A1 (AU)
Title: Reference picture resampling with switchable filters
Inventor: SEREGIN VADIM
IPC: H04N19/132
Filed: 2020-06-26
Abstract: Techniques are described for video encoding and decoding using reference picture resampling with switchable filters. One example involves obtaining a current picture and a reference picture, identifying filter index information for a current block of the current picture, and determining that a first picture size value of the current picture and a second picture size value of the reference picture are different. Based on the determining that the first picture size value of the current picture and the second picture size value of the reference picture are different, performing a resampling process using a default filter index in place of a current filter index identified by the filter index information. Additional examples can use the current filter index identified by the filter index information in subsequent blocks. In various examples, the current filter index can be derived or signaled.
Patent AU-2020334237-A1 (AU)
Title: Cell therapy methods
Inventor: GRÄHLERT JASMIN
IPC: A61K39/00
Filed: 2020-08-19
Abstract: The present invention is in the field of cell therapy and provides compositions and methods for treating cancer and/or viral infections in patients. The invention provides lymphocytes comprising a synthetic polynucleotide encoding at least one iron regulatory protein and, optionally, a chimeric antigen receptor. The invention further provides methods for producing these lymphocytes and administering them to patients.
Patent AU-2020352898-A1 (AU)
Title: Method for signaling output subpicture layer set
Inventor: CHOI BYEONGDOO
IPC: H04N9/75
Filed: 2020-09-11
Abstract: A method, computer program, and computer system is provided for coding a video sequence. Video information corresponding to one or subpictures within a picture is received. A first subpicture is identified from among the one or more subpictures as a region of interest. The first subpicture corresponding to the region of interest is encoded in a high quality mode. One or more other subpictures from among the one or more subpictures is encoded in a low quality mode. The first encoded subpicture and the encoded one or more other subpictures are output with one or more output layer sets.
Patent AU-2020362115-A1 (AU)
Title: Compositions and methods for pulmonary surfactant-biomimetic nanoparticles
Inventor: Wu Mei Xiong
IPC: A61K45/00
Filed: 2020-10-06
Abstract: Compositions and methods comprising Pulmonary Surfactant (PS)-biomimetic nanoparticles are disclosed. Specifically, the disclosure is related to a composition comprising a nanoparticle with an average size of 200-400 nm, including a plurality of pulmonary surfactant biomimetic molecules, wherein the nanoparticle is negatively charged; and one or more cargo molecules that are enveloped by the nanoparticle, wherein the cargo molecule has a molecular weight up to 1200 Da.
Patent AU-2020364088-A1 (AU)
Title: Optical subcarrier dual-path protection and restoration for optical communications networks
Inventor: HAND STEVEN JOSEPH
IPC: H04J14/02
Filed: 2020-10-09
Abstract: An example system includes a first network device having first circuitry. The first network device is configured to perform operations including receiving data to be transmitted to a second network device over an optical communications network, and transmitting first information and second information to the second device. The first information is indicative of the data, and is transmitted using a first communications link of the optical communications network and using a first subset of optical subcarriers. The second information is indicative of the data, and is transmitted using a second communications link of the optical communications network and using a second subset of optical subcarriers. The first subset of optical subcarriers is different from the second subset of optical subcarriers.
Patent AU-2020386521-A1 (AU)
Title: Systems and methods for spatial analysis of analytes using fiducial alignment
Inventor: WEISENFELD NEIL IRA
IPC: G06T7/136
Filed: 2020-11-18
Abstract: Systems and methods for spatial analysis of analytes are provided. A data structure is obtained comprising an image, as an array of pixel values, of a sample on a substrate having an identifier, fiducial markers and a set of capture spots. The pixel values are used to identify derived fiducial spots. The substrate identifier identifies a template having reference positions for reference fiducial spots and a corresponding coordinate system. The derived fiducial spots are aligned with the reference fiducial spots using an alignment algorithm to obtain a transformation between the derived and reference fiducial spots. The transformation and the template corresponding coordinate system are used to register the image to the set of capture spots. The registered image is then analyzed in conjunction with spatial analyte data associated with each capture spot, thereby performing spatial analysis of analytes.
Patent AU-2020388523-A1 (AU)
Title: Needle biopsy device
Inventor: ROHL JAMES P
IPC: A61B10/04
Filed: 2020-10-28
Abstract: A device includes a hollow needle with a lumen extending therethrough. The needle is sized and shaped to extend through an endoscopic shaft to a target tissue within a living body. The needle has a distal end with a sharpened distal tip for puncturing the target tissue and removing a portion of the tissue in the lumen. The device further includes a cylindrical stylet having a shaft sized and shaped to extend through the lumen of the needle and a distal end with a pointed distal tip for puncturing the target tissue. When the stylet is extended, the pointed distal tip of the stylet extends distally a predetermined distance past the sharpened distal tip of the needle.
Patent AU-2020394211-A1 (AU)
Title: Designed bacterial compositions and uses thereof
Inventor: MARTINEZ ASUNCION
IPC: A61K35/74
Filed: 2020-11-25
Abstract: Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with dysbiosis of a gastrointestinal tract. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
Patent AU-2020400248-A1 (AU)
Title: Device for guiding a flexible line
Inventor: FIACK THOMAS
IPC: B05B15/656
Filed: 2020-10-26
Abstract: The invention relates to a device suitable for guiding a flexible line, in particular a hose (12). In order to develop the device (10) in such a manner that it permits an adjustable change in direction of the guidance of the flexible line, the device (10) has a joint arrangement (22) with a first joint part (24) and a second joint part (26) which are pivotable relative to each other about a joint axis (28) and form a guide channel for the flexible line, wherein the guide channel has an inlet section (34), an outlet section (44) and a variable-length connecting section (120) connecting the inlet section (34) to the outlet section (44), wherein the connecting section (120) is covered on its outer side facing away from the joint axis (28) by a deformable cover part (122) which is mounted movably at least on one of the two joint parts (24).
Patent AU-2020408198-A1 (AU)
Title: Methods and vaccine compositions to treat cancers
Inventor: POYET JEAN-LUC
IPC: A61P35/02
Filed: 2020-12-18
Abstract: The present invention relates to a method for obtaining a population of oncogenic cells modified comprising the following steps: i) obtaining a population of oncogenic cells from a subject suffering from a cancer; and ii) treating said cells with a fusion protein comprising an AAC-11 leucine-zipper (LZ) derived peptide which is fused to at least one heterologous polypeptide. Inventors have evaluated here the antileukemic efficacy of RT53, an anticancer peptide with potential immunological properties. Their results indicate that RT53 possesses a direct antileukemic effect, even at late stage. They also demonstrated that single injection of a vaccine consisting of leukemic blasts exposed to RT53, which induces the hallmarks of immunogenic cell death, was highly effective in preventing leukemia development in both prophylactic and therapeutic settings. The vaccine comprising RT53-treated APL cells generated long-term antileukemic protection and depletion experiments indicated that CD4+ T cells were of crucial importance for vaccine efficacy. Combined, their results provide the rational for the exploration of RT53-based therapies for the treatment of cancer, such as acute leukemia.
Patent AU-2020466800-A1 (AU)
Title: Pharmaceutical composition for prevention and/or treatment of dialysis pruritus containing IL-31 antagonist as active ingredient
Inventor: FUKAZAWA NAOKI
IPC: A61P25/20
Filed: 2020-09-01
Abstract: The present invention provides, in a non-limiting embodiment, a pharmaceutical composition for prevention and/or treatment of dialysis pruritus, the composition containing IL-31 antagonist as an active ingredient.
Patent AU-2021202370-A1 (AU)
Title: Traffic radar system with automated tuning fork test feature
Inventor: SHELTON MAURICE E
IPC: G01S13/92
Filed: 2021-04-19
Abstract: A traffic radar system (TRS) utilizing an automated test process which aids the 
operator in quickly conducting comprehensive system tuning fork tests that includes front and 
rear antennas and stationary, moving opposite, and moving same-lane operations. The 
automated process has the ability to select the proper radar antenna and proper mode of operation 
for each step of the test. The process will measure the input fork signals and report if the signals 
are within the specified tolerance. Optionally, the process can be set to not allow the radar 
system to enter the normal operating mode if the tuning fork tests have not been successfully 
completed.
Patent AU-2021204364-A1 (AU)
Title: Methods For Sorting Nucleic Acids and Multiplexed Preparative In Vitro Cloning
Inventor: JACOBSON JOSEPH
IPC: C12N15/10
Filed: 2021-06-25
Abstract: Methods and compositions relate to the sorting and cloning of high fidelity nucleic acids 
using high throughput sequencing. Specifically, nucleic acid molecules having the desired 
predetermined sequence can be sorted from a pool comprising a plurality of nucleic acids 
having correct and incorrect sequences.
Patent AU-2021211426-A1 (AU)
Title: Robotic harvesting systems and methods
Inventor: KNOPF RYAN R
IPC: A01D46/20
Filed: 2021-01-20
Abstract: Robotic systems and methods for harvesting agricultural produce along multiple rows crops are disclosed. A mobile platform may include a robotic arm having a gripping tool and repositionable catch for collecting harvested target objects. A vision system may facilitate the identification of target objects and an associated controller may coordinate the various operational functions.
Patent AU-2021212025-A1 (AU)
Title: Intelligent question answering on tabular content
Inventor: JOY ELDHOSE
IPC: G06N5/04
Filed: 2021-08-04
Abstract: An intelligent table-based question answering system receives an input user query 
requesting information from an input table to generate a response to the input query. Two 
types of user queries including textual user queries and scalar user queries that require at 
least one mathematical operation to be executed can be processed for answer generation.  
The input table is processed to generate a paragraph of table text which includes row and 
column information extracted from the input table. The input query is provided along with 
the paragraph of table text to a deep Quans model which outputs a candidate answer that 
forms a textual portion of the response. Also, the candidate answer is reverse mapped to 
the input table and a portion of the input table including the candidate answer is provided as 
a tabular portion of the response.
1/12 
If) 0 0 
'-4-E 
U) 0 0 
on c~- 4 - t 
c I- I-U* 
0 MJ 
x 0 
D C) 0 CV) 
- o _lj C 
CDCl Cl)o 
zl z C14 
0 HO 
0 ) LuA
< H 
C Lu 
U)4  H ZL 
zZwU) C 
<) < -J U~C)C w 
z U) C 
0~ 
U)) 
0 w 
0~U .ta 
=~~. TU)zC wC 
) U4-0 
co) a) 
CLC
Patent AU-2021212077-A1 (AU)
Title: Conductive optical element
Inventor: MILLER SCOTT
IPC: G02B1/116
Filed: 2021-08-05
Abstract: A device having an optical element with a conductive coating. The device may include an 
optical element, a conductive material and at least one connector. The conductive material is 
disposed on at least a portion of the optical element. The optical element, for example, may be 
an object lens of an endoscope or an optical coupler. The connectors (acting as terminals) are 
capable of providing energy (such as electrical energy) to the conductive material. In one 
aspect, the conductive material is an optically transparent material. Advantageously, the device 
may allow visualization of an object - such as body tissue or other matter - concurrent with the 
application of energy to the object via the conductive coating. This allows the user to observe 
the alteration of tissue and other matter in real time as the energy is delivered.
Patent AU-2021212223-A1 (AU)
Title: Compositions comprising bacterial strains
Inventor: MULDER Imke Elisabeth
IPC: A61P25/08
Filed: 2021-01-27
Abstract: A composition comprising a bacterial strain of the species Enterococcus durans, for use in a method of treating or preventing a central nervous system disorder or condition.
Patent AU-2021215097-A1 (AU)
Title: Combined structure
Inventor: SONG KEUN CHUL
IPC: E02F9/28
Filed: 2021-08-09
Abstract: OF THE DISCLOSURE 
Disclosed is a combined structure, and the combined structure includes a coupling 
target object having a coupling space that comprises a first space and a second space 
5 communicating with each other, a damper structure accommodated in the first space and 
including a flexible portion having a hollow therein and a hard portion coupled to the flexible 
portion and having one surface exposed to an outside, and a coupling unit accommodated in 
the second space, a portion of which is in contact with one surface of the hard portion. The 
hollow is closed from the outside in the damper structure. In response to rotation of the 
10 coupling unit in the second space, another portion different from the portion of the coupling 
unit comes into contact with the hard portion. When the coupling unit rotates in one 
direction from an initial state, in which the coupling unit is inserted into the second space, to 
become a first rotation state, a portion where the coupling unit and the hard portion contact 
each other is moved in a direction toward the flexible portion further than the initial state, and 
5 thus, the hard portion is moved in the direction toward the flexible portion further than the 
initial state. The flexible portion is compressed and deformed between the hard portion and 
an inner surface of the coupling target object forming the first space.
[FIG. 8] 
H111 13 32 3131 200 
11~13 :10 
S11 S12 31, 32 :30 
1231 
...... ......... 3 1 3 2 
(a)20 
H111 13 ()3131 S12 200 
11-13 :10 
S1132 31, 32 : 30 
31 
I L 3132 
H111 13 3131 200 
11-13 :10 
S11 51231, 32 : 30 
12 32 
---31 
(c) 3132
Patent AU-2021215267-A1 (AU)
Title: System and method for preparing hollow core cranial remodeling orthoses
Inventor: GOODNOUGH JASON SHANE
IPC: A61F5/058
Filed: 2021-08-13
Abstract: A system for creating cranial remolding orthoses comprises a controller in data communication with an 
additive fabricator and a scanner. The controller has access to a database of mappings of nonstandard 
cranial shapes to desired cranial shapes, to cranial scan data for a patient with an existing cranium 
shape, and to patient-specific information about the patient. The controller has design software for 
determining from the scan data a development path from the existing cranium shape to a desired 
cranium shape, the development path comprising a plurality of development path stages. Fabrication 
software in the controller allows it to instruct the fabricator for fabricating a cranial remodeling 
orthoses corresponding to the development path without requiring a physical model. The orthoses 
comprise a monolithic hollow core shell of thickness varying according to the desired remodeling of the 
cranium, an inner soft liner, and a fastener disposed for mounting the orthoses on the cranium of the 
patient.  
22
Patent AU-2021218009-A1 (AU)
Title: L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
Inventor: NAXOS PAGE PATRICK
IPC: A61K45/06
Filed: 2021-08-16
Abstract: The invention provides the L-valinate ester of a hydroxypropylthiazolidine 
carboxamide derivative of formula (I), (2S)-3-([1,1'-biphenyl]-4-ylsulfonyl)-N-[(1S)-3
hydroxy-1- phenylpropyl]-1,3-thiazolidine-2- carboxamide, as well as salts and crystal 
polymorphs thereof. The compound inhibits the prostaglandin F receptor (PGF2alpha) 
and is useful in the treatment of disorders such as preterm labor at the early 
gestational stage or dysmennorrhea.
Patent AU-2021218020-A1 (AU)
Title: Fastening Means For Implantable Medical Control Assembly
Inventor: FORSELL PETER
IPC: A61F2/02
Filed: 2021-08-16
Abstract: A control assembly for implantation in a patient comprises a first unit adapted for subcutaneous 
implantation at a first side of a body tissue of said patient, a second unit adapted for implantation in a 
body cavity of said patient at a second side of said body tissue, wherein at least one of the first and the 
second unit is adapted to control an implanted powered medical device, and an interconnecting device 
adapted for mechanical interconnection of the first and second units to keep the assembly in place by 
the body tissue, the interconnecting device having a cross-sectional area which is smaller than the 
cross-sectional area of the first unit and the second unit in a plane parallel to the extension of the body 
tissue.  
Fig 2
1/15 
FigA Fig. 2 
20 
10 30 40 3a 
110 
Fig. 3a 
10 30 20 
Fig 3 b 10 
Fig.3 c 
20 20 
30
Patent AU-2021221905-A1 (AU)
Title: Gene expression profiles associated with sub-clinical kidney transplant rejection
Inventor: SALOMON DANIEL
IPC: C12Q1/68
Filed: 2021-08-27
Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative 
gene sequences in peripheral blood, the present inventors have identified a consensus set of 
gene expression-based molecular biomarkers associated with subclinical acute rejection 
(subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.